John Murray-Pryce

John Murray-Pryce, Ph.D., is a Life Sciences leader with over 25 years of experience driving innovation in Biopharmaceutical R&D at industry giants AstraZeneca and Merck & Co. A chemical engineer by training, John is passionate about leveraging cutting-edge technologies to bring life-changing therapies to patients.  Throughout his successful career, John has held senior leadership roles across pharmaceutical and clinical development, spanning oncology, respiratory, and cardiovascular diseases. His accomplishments include spearheading global digital transformation programs that significantly reduced drug development timelines and costs through advancements in patient recruitment and clinical supply chain management. John’s leadership was also instrumental in the development and commercialisation of Lynparza, a revolutionary new cancer therapy.  Currently, John is dedicated to bridging the gap between digital innovation and healthcare and is actively collaborating with technology CROs and universities in order to achieve this mission.